Arax Advisory Partners’s Ligand Pharmaceuticals LGND Stock Holding History
Bought
Maintained
Sold
Other funds holding LGND
JT
CAM
Arax Advisory Partners's LGND Position: Q2 2026 in Review
Arax Advisory Partners opened a new position in Ligand Pharmaceuticals (LGND) in Q2 2026: 347 shares worth $110K. The stake represents ﹤0.01% of the portfolio and ranks #2664 among its holdings. This is a return to the name: Arax Advisory Partners previously reported a position in LGND as recently as Q4 2025.
Arax Advisory Partners first reported a position in LGND in Q2 2024 and has held it in 7 quarters since. 414 funds tracked by Wall St. Rank hold LGND as of Q2 2026.
- Arax Advisory Partners held 347 shares of Ligand Pharmaceuticals worth $110K as of Q2 2026.
- Ligand Pharmaceuticals was a new Arax Advisory Partners position in Q2 2026.
- Ligand Pharmaceuticals made up ﹤0.01% of Arax Advisory Partners's portfolio in Q2 2026, its #2664 holding.
- Arax Advisory Partners first reported a position in Ligand Pharmaceuticals in Q2 2024 and has held it in 7 quarters since.
- 414 funds tracked by Wall St. Rank held Ligand Pharmaceuticals as of Q2 2026.
Based on Arax Advisory Partners's 13F filing for Q2 2026, filed 10 Aug 2026.